Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on chiral resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1156474C details novel chiral isoquinoline synthesis offering improved solubility and bioavailability for cardiovascular drug manufacturing.
Patent CN102887885B details high-purity esomeprazole sodium synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN1403456A details a novel resolution and quaternization process for chiral tetrahydroberberine, offering cost reduction in cardiovascular drug manufacturing and enhanced supply chain reliability.
Discover the asymmetric transformation method for L-2-aminobutanamide hydrochloride. Enhance purity and reduce costs in levetiracetam manufacturing with our advanced synthesis route.
Novel diastereoselective alkylation route for high-purity anti-atherosclerotic intermediates, offering significant cost reduction and scalable manufacturing for global supply chains.
Patent CN109734653A details novel resolution for Argatroban intermediates ensuring high purity and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN110256261B details a novel copper-coordinated chiral resolution method for high-purity L-2-amino-1-butanol, offering significant supply chain and cost advantages.
Patent CN1184109A reveals a novel diastereoselective synthesis for high-purity cycloalkanol indole carboxylic acids, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN104163821A enables high-yield diazabicyclo compound production. Reduces costs and ensures supply continuity for pharmaceutical manufacturers globally.
Novel route for GABA-T inhibitor precursor via lactam rearrangement offering cost reduction and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN114716375A details a novel chiral resolution process achieving >99.9% optical purity for Mivacurium intermediates, ensuring superior safety and scalable manufacturing.
Novel resolution method for high-purity chiral pyrazolo isoquinoline. Cost-effective scalable process for PARP inhibitor intermediates ensuring supply chain reliability.
Patent CN102796065A details a novel resolution and cyclization route for S-escitalopram, offering superior optical purity and simplified manufacturing for global pharmaceutical supply chains.
Advanced synthesis of stable Clopidogrel Hydrogen Sulfate Form II via optimized solvent strategy. High purity, reduced waste, and scalable manufacturing for global supply chains.
Patent CN101142211B details a robust resolution process for cis-oxathiolane cytosine derivatives, offering significant cost reduction and supply chain reliability for antiviral API manufacturing.
Patent CN114591219A details a water-based resolution process for S-3-aminopiperidine dihydrochloride, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Novel resolution process using L-tartaric acid improves purity >99.8% and reduces costs for reliable pharma intermediate suppliers.
Patent CN102399166B enables high-purity THPBs synthesis. Reduces cost and improves supply chain reliability for neurological drug intermediates.
Novel five-step route avoids hazardous HMPA and cryogenic conditions. Delivers high purity pharmaceutical intermediates with scalable industrial production capabilities.
Patent CN103012264A details a robust resolution method for (R)-3-amino-hexahydro-1H-azepane using tartaric acid, ensuring superior optical purity for ophthalmic antibiotics.